Yamagata University · University Hospital

Research keywordshematologic malignancies・multiple myeloma・mantle cell lymphoma・acute leukemia-associated DIC・pure red cell aplasia・iron deficiency biomarkers・anti-ganglioside neuropathy・recombinant thrombomodulin

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Elranatamab in Japanese patients with relapsed/refractory multiple myeloma: results from MagnetisMM-2 and MagnetisMM-3 ，japanese journal of clinical oncology，2024年09月2024 · Shinsuke Iida,Satoshi Ito,Hisayuki Yokoyama
• Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma ，international journal of clinical oncology，29(2) 232-240，2024年02月2024 · Hideki Goto,Satoshi Ito,Masahiro Kizaki,masaki Yamaguchi
• [Immune-mediated neuropathy with anti-ganglioside antibodies in diffuse large B-cell lymphoma].，[Rinsho ketsueki] The Japanese journal of clinical hematology，60(7) 761-766，2019年2019 · Yanagiya R, Ito S, Yamada A, Aizawa K, Shiono Y, Inokura K, Toubai T, Kato Y, Honda K, Ishizawa K
• Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum.，International journal of hematology，105(5) 606-613，2017年05月2017 · Yokoyama H, Takahashi N, Katsuoka Y, Inomata M, Ito T, Meguro K, Kameoka Y, Tsumanuma R, Murai K, Noji H, Ishizawa K, Ito S, Onishi Y, Harigae H, Tohoku Hematology Forum

• Official profile